The increased fluorescence intensity of Ang1 suggests that aCD19 Ab treatment exerts a protective and pro-angiogenic effect on damaged neural and vascular structures following stroke (Figure 4a, Supplementary Figure S3a). Here, ANGPT1 is linked to stroke disorder.